← Leaderboards
Michael J Polydefkis
Johns Hopkins University
$734,614
Attributed
$734,614
Total exposure
7
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $154.9K · FY2005–07$200K$150K$100K$50K$0
'05
'06
'07
Funding mix
By agency
NIH$734,614 · 7
By mechanism
K23$656,940 · 1
M01$77,674 · 5
U01$0 · 1
Top collaborators
No co-investigators on record.
Most similar at Johns Hopkins University
Same institution · by research overlap
- Justin C McArthur$21,339,205
- Michael A. Carducci$23,642,506
- Ahmet Hoke$10,977,966
- James A Tonascia$68,672,260
- Joseph L Mankowski$32,075,460
Others in their field
Top investigators on “Diabetic Neuropathy”
- John M Lachin · George Washington University$140,240,809
- David M Nathan · Massachusetts Institute Of Technology$122,561,681
- Rose A Gubitosi-Klug · Case Western Reserve University$72,618,151
- Marinella Temprosa · George Washington University$50,368,680
- Sarah E. Fowler · George Washington University$21,856,947
- Maurizio Fava · Massachusetts General Hospital$19,316,294
Research focus
Diabetic NeuropathyBiopsyModel Design /DevelopmentDisease /Disorder ModelImmunocytochemistryHuman Therapy EvaluationNerve InjuryPatient Oriented ResearchHuman SubjectTechnology /Technique DevelopmentSkinCapsaicinDiabetes MellitusBiomarkerNeurofilamentNeuropharmacologic AgentAxonNervous System RegenerationGene ExpressionNeuronal GuidancePsychological TestsNerve EndingsCutaneous Sensory NerveFluorescence Microscopy
Grant awards (15)
EFFICACY AND SAFETY OF FK1706$3,376
M01 · FY2007 · RR · contact PI
GABAPENTIN AND TRAMADOL IN THE TREATMENT OF SMALL FIBER PREDOMINANT NEUROPATHY$1,644
M01 · FY2006 · RR · contact PI
HUMAN AXONAL REGENERATION IN DIABETIC NEUROPATHY$131,388
K23 · FY2005 · NS
TOPIRAMATE VERSUS PLACEBO IN A CAPSAICIN NERVE INJURY MODEL$13,209
M01 · FY2005 · RR
A TRIAL OF GABAPENTIN IN RESTLESS LEGS SYNDROME$9,581
M01 · FY2005 · RR
GABAPENTIN AND TRAMADOL IN THE TREATMENT OF SMALL FIBER PREDOMINANT NEUROPATHY$748
M01 · FY2005 · RR
HUMAN AXONAL REGENERATION IN DIABETIC NEUROPATHY$131,388
K23 · FY2004 · NS
Topiramate Versus Placebo in a Capsaicin Nerve Injury Model$44,186
M01 · FY2004 · RR
A Trial of Gabapentin in Restless Legs Syndrome$4,930
M01 · FY2004 · RR
HUMAN AXONAL REGENERATION IN DIABETIC NEUROPATHY$131,388
K23 · FY2003 · NS
HUMAN AXONAL REGENERATION IN DIABETIC NEUROPATHY$131,388
K23 · FY2002 · NS
Models of Diabetic Neuropathy$0
U01 · FY2002 · DK
Models of Diabetic Neuropathy$0
U01 · FY2002 · DK
HUMAN AXONAL REGENERATION IN DIABETIC NEUROPATHY$131,388
K23 · FY2001 · NS
Models of Diabetic Neuropathy$0
U01 · FY2001 · DK